CDSCO approves extension of Bharat Biotech’s Covaxin’s shelf life
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's shelf life up ...
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's shelf life up ...
Two doses of Bharat Biotech's COVID-19 vaccine 'Covaxin' are 50 per cent effective against symptomatic disease, according to the first ...
The UN body “trusts” the Indian industry that manufactures high quality vaccines, a top official of the global health agency ...
Hyderabad-based Bharat Biotech concluded a final analysis for its vaccine Covaxin efficacy from a phase-3 clinical trial, which claimed it ...
The United Kingdom has approved a dose of Pfizer COVID vaccine for children aged 12 to 15 years. Britain's drug ...
The results of the Phase III trial of COVAXIN, a vaccine from Corona developed by Bharat Biotech and ICMR, have ...
India launched the world's biggest vaccination drive with two 'Made in India vaccines- Covishield and Covaxin- against the coronavirus disease ...
DCGI on Sunday approved the use of two Covid vaccines in the country amid Corona pandemic. Two vaccines that DCGI ...